NEW YORK – French in vitro diagnostics firm Eurobio Scientific said on Monday it has reached a deal with CirrusDx to commercialize its molecular biology platform, T-COR 8, in France and in the Maghreb countries of North Africa.
Financial and other terms of the deal were not disclosed. The Maghreb countries include Algeria, Libya, Mauritania, Morocco, Tunisia, and Western Sahara.
T-COR 8 is a real-time PCR thermocycler originally developed for the US Army and offered by Tetracore Group. CirrusDx, headquartered in Rockville, Maryland, is the commercial arm of Tetracore. The instrument is highly compact and mobile and can be used for emergency or decentralized applications at the point of care, Eurobio said in a statement.
The company added that T-COR 8 is designed to run assays individually in real time and has eight independent wells, allowing for the simultaneous analyses of up to eight patient samples.
Paris-based Eurobio said it will develop a new range of proprietary products for the T-COR 8 instrument, which will complement the EurobioPlex suite of tests already available for use with Seegene's high-speed multiplex platform.
The new kits will include tests for detecting pathogens, including those for infectious diseases such as meningitis (viruses and bacterial) and viral diseases including Dengue fever. Eurobio plans to pursue CE-IVD marking for the new tests. It added that five kits have been CE-marked and plans to get such designation for 15 other tests.